TreeFrog Therapeutics, a leading biotechnology company specializing in cell therapies, has recently enhanced its Executive Team with the addition of three accomplished professionals. Among the new appointments are Jaime Arango as Chief Financial Officer, Jens Schröder as Chief Medical Officer, and Rachel Mooney as Chief Communications Officer. These appointments align with the company’s mission to advance cell therapies through cutting-edge technology.
Jaime Arango, a financial leader with a successful track record at Medincell, brings his expertise to TreeFrog Therapeutics as the newly appointed Chief Financial Officer. Additionally, Jens Schröder, who previously oversaw clinical development at Bayer, joined the team as the Chief Medical Officer. Lastly, Rachel Mooney, an experienced communications executive at companies such as Sanofi and Galderma, is set to lead the communications department as the Chief Communications Officer. These additions to the Executive Team represent TreeFrog’s commitment to propelling its revolutionary cell therapy technology forward.
Frederic Desdouits, Ph.D., the CEO of TreeFrog Therapeutics, expressed his pride in the company’s growth and emphasized the significance of reinforcing the Executive Committee for the next phase of expansion. The newly appointed executives are expected to play a crucial role in the company’s future success by leveraging their diverse skills and expertise. For more information on TreeFrog Therapeutics’ Executive Team, visit their website at www.treefrog.fr.
